Carriero MV - Search Results

1

Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.

Gargiulo L, Longanesi-Cattani I, Bifulco K, Franco P, Raiola R, Campiglia P, Grieco P, Peluso G, Stoppelli MP, Carriero MV. Gargiulo L, et al. Among authors: carriero mv. J Biol Chem. 2005 Jul 1;280(26):25225-32. doi: 10.1074/jbc.M412605200. Epub 2005 May 2. J Biol Chem. 2005. PMID: 15866865 Free article.

2

Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.

Caputo TM, Cusano AM, Principe S, Cicatiello P, Celetti G, Aliberti A, Micco A, Ruvo M, Tagliamonte M, Ragone C, Minopoli M, Carriero MV, Buonaguro L, Cusano A. Caputo TM, et al. Among authors: carriero mv. Int J Nanomedicine. 2023 Jul 26;18:4121-4142. doi: 10.2147/IJN.S415968. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37525693 Free PMC article.

3

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.

Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, et al. Del Vecchio S, et al. Among authors: carriero mv. Cancer Res. 1993 Jul 1;53(13):3198-206. Cancer Res. 1993. PMID: 7686450

4

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.

Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Carriero MV, et al. Cancer Res. 1994 Oct 15;54(20):5445-54. Cancer Res. 1994. PMID: 7923178

5

In vitro receptor imaging for characterization of human solid tumors.

Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, et al. Del Vecchio S, et al. Among authors: carriero mv. Nucl Med Biol. 1994 Jul;21(5):771-4. doi: 10.1016/0969-8051(94)90048-5. Nucl Med Biol. 1994. PMID: 9241653

6

Vitronectin binding to urokinase receptor in human breast cancer.

Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M. Carriero MV, et al. Clin Cancer Res. 1997 Aug;3(8):1299-308. Clin Cancer Res. 1997. PMID: 9815812

7

Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.

Chiaradonna F, Fontana L, Iavarone C, Carriero MV, Scholz G, Barone MV, Stoppelli MP. Chiaradonna F, et al. Among authors: carriero mv. EMBO J. 1999 Jun 1;18(11):3013-23. doi: 10.1093/emboj/18.11.3013. EMBO J. 1999. PMID: 10357814 Free PMC article.

8

Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.

Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli MP. Carriero MV, et al. Cancer Res. 1999 Oct 15;59(20):5307-14. Cancer Res. 1999. PMID: 10537314

9

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.

Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Zannetti A, et al. Among authors: carriero mv. Cancer Res. 2000 Mar 15;60(6):1546-51. Cancer Res. 2000. PMID: 10749121

10

Inhibition of receptor-dependent urokinase signaling by specific Ser to Glu substitutions.

Carriero MV, Franco P, Gargiulo L, Vocca I, Cito L, Fontana L, Iaccarino C, Del Pozzo G, Guardiola J, Stoppelli MP. Carriero MV, et al. Biol Chem. 2002 Jan;383(1):107-13. doi: 10.1515/BC.2002.011. Biol Chem. 2002. PMID: 11928806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters